Approach

Our rigorous investment process combines a deep understanding of biology, unmet needs in medicine, and building high-performing companies to bring medical breakthroughs to patients.

Support at all stages

We bring deep industry experience, creativity, and candor to visionary biotech teams at all stages of their journeys.

Guided by the science

We work diligently to connect the dots between cutting-edge science and well-defined clinical need.

Committed to the cause

Our investments have yielded multiple new drug approvals and device clearances by the FDA and other regulatory bodies, and our ambition is to build boldly on this legacy, continually improving lives across the globe.

Since our founding in 2014, we have proudly supported a portfolio of visionary life sciences companies that are advancing medicine.